At a glance
- Originator Wyeth
- Class Benzonitrile
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Urinary incontinence
Most Recent Events
- 20 Oct 2005 Discontinued - Preclinical for Urinary incontinence in USA (unspecified route)
- 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth
- 09 Nov 2000 Profile reviewed but no significant changes made